Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$111,667
+$1,433 QoQ
Shares Held
1,921
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#237
of 329 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names. PCVX ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,909 | $12,869,777 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
17,228 | $5,445,598 | |
| 3 | INCY |
Incyte Corp
|
24,359 | $2,761,336 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
95,934 | $2,515,389 | |
| 5 | ASND |
Ascendis Pharma A/S
|
9,146 | $2,439,421 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
21,896 | $2,431,112 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,379 | $1,483,401 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
15,280 | $1,246,389 |
All Filings in PCVX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,667 | 1,921 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $110,234 | 1,897 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,681 | 1,922 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $69,266 | 1,923 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $62,744 | 1,930 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $72,839 | 1,929 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $86,935 | 1,062 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||